Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Duong

Showing results (261-270 of 281) with videos related to

Pageof 29
Sort By:
Ejhaem|March 11, 2021
Increased body mass index is a risk factor for acute promyelocytic leukemiaSarah M Kashanian, Andrew Y Li, Moaath Mustafa Ali, et al.
Cancer Chemotherapy and Pharmacology|November 10, 2017
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemiaAshkan Emadi, Jennie Y Law, Erin T Strovel, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginaseJoseph F Mort, David Brighton, Benjamin Mautner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with GuadecitabineCasey L O'Connell, Maria R Baer, Andreas Due Ørskov, et al.
Journal of Clinical Medicine|April 5, 2020
People with Suspected COVID-19 Symptoms Were More Likely Depressed and Had Lower Health-Related Quality of Life: The Potential Benefit of Health LiteracyHoang C Nguyen, Minh H Nguyen, Binh N Do, et al.
Epilepsy & Behavior : E&B|July 31, 2025
Depressive symptoms in youth with refractory epilepsy: Exploration of seizure, sociodemographic and cognitive factorsS B Brothers, C Wolfe-Christensen, H J Loblein, et al.
Nutrients|June 24, 2022
The Associations of Suspected COVID-19 Symptoms with Anxiety and Depression as Modified by Hemodialysis Dietary Knowledge: A Multi-Dialysis Center StudyLoan T Dang, Thuc C Luong, Dung H Nguyen, et al.
Heart, Lung & Circulation|March 19, 2025
An Expert Opinion on the Management of Frailty in Heart Failure from the Australian Cardiovascular Alliance National TaskforceJulee McDonagh, Caleb Ferguson, Sarah N Hilmer, et al.
Epilepsia|March 10, 2023
Leveraging expertise and optimizing clinical research: Initial success of a pediatric epilepsy surgery collaborativeMadison M Berl, Jennifer I Koop, Alyssa Ailion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed <i>NPM1</i>-Mutated or <i>KMT2A</i>-Rearranged AMLJoshua F Zeidner, Tara L Lin, Rina Li Welkie, et al.
Pageof 29

Showing results (261-270 of 281) with videos related to

Sort By:
Pageof 29
Ejhaem|March 11, 2021
Increased body mass index is a risk factor for acute promyelocytic leukemiaSarah M Kashanian, Andrew Y Li, Moaath Mustafa Ali, et al.
Cancer Chemotherapy and Pharmacology|November 10, 2017
Asparaginase Erwinia chrysanthemi effectively depletes plasma glutamine in adult patients with relapsed/refractory acute myeloid leukemiaAshkan Emadi, Jennie Y Law, Erin T Strovel, et al.
Blood Vessels, Thrombosis & Hemostasis|August 6, 2025
Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginaseJoseph F Mort, David Brighton, Benjamin Mautner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 12, 2022
Safety, Outcomes, and T-Cell Characteristics in Patients with Relapsed or Refractory MDS or CMML Treated with Atezolizumab in Combination with GuadecitabineCasey L O'Connell, Maria R Baer, Andreas Due Ørskov, et al.
Journal of Clinical Medicine|April 5, 2020
People with Suspected COVID-19 Symptoms Were More Likely Depressed and Had Lower Health-Related Quality of Life: The Potential Benefit of Health LiteracyHoang C Nguyen, Minh H Nguyen, Binh N Do, et al.
Epilepsy & Behavior : E&B|July 31, 2025
Depressive symptoms in youth with refractory epilepsy: Exploration of seizure, sociodemographic and cognitive factorsS B Brothers, C Wolfe-Christensen, H J Loblein, et al.
Nutrients|June 24, 2022
The Associations of Suspected COVID-19 Symptoms with Anxiety and Depression as Modified by Hemodialysis Dietary Knowledge: A Multi-Dialysis Center StudyLoan T Dang, Thuc C Luong, Dung H Nguyen, et al.
Heart, Lung & Circulation|March 19, 2025
An Expert Opinion on the Management of Frailty in Heart Failure from the Australian Cardiovascular Alliance National TaskforceJulee McDonagh, Caleb Ferguson, Sarah N Hilmer, et al.
Epilepsia|March 10, 2023
Leveraging expertise and optimizing clinical research: Initial success of a pediatric epilepsy surgery collaborativeMadison M Berl, Jennifer I Koop, Alyssa Ailion, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 12, 2025
Azacitidine, Venetoclax, and Revumenib for Newly Diagnosed <i>NPM1</i>-Mutated or <i>KMT2A</i>-Rearranged AMLJoshua F Zeidner, Tara L Lin, Rina Li Welkie, et al.
Pageof 29